Low Energy Diet and Familial Partial Lipodystrophy
Evaluating the Therapeutic Efficacy and Metabolic Impact of a Low Energy Diet (LED) in People With Familial Partial Lipodystrophy and Diabetes
Cambridge University Hospitals NHS Foundation Trust
20 participants
Jan 16, 2020
INTERVENTIONAL
Conditions
Summary
To evaluate the therapeutic efficacy and metabolic impact of a low energy diet (LED) in people with familial partial lipodystrophy and diabetes. Participants will be provided with a LED (total diet replacement) for 12 weeks, before the introduction of a stepped food transition. Metabolic effects will continue to be assessed for 1 year. In order to better understand why this intervention changes insulin sensitivity, we will also collect adipose and muscle tissue samples at baseline and 12 weeks into the intervention in participants willing to have these procedures performed. These samples will be used for histological, metabolite, gene expression and protein expression analyses.
Eligibility
Inclusion Criteria7
- Familial Partial Lipodystrophy
- Age \>= 18 yrs
- T2DM
- Willingness to check daily blood sugars
- HbA1c between 53mmol(7%)- 108 mmol(12%)
- Weight stable for 3 months
- Capacity to consent
Exclusion Criteria8
- Pregnancy
- Untreated thyroid dysfunction (patients who have been euthyroid on medication for at least 3 months can be included)
- Use of medication adversely that affects diabetes control (e.g. steroids/ immunosuppressants/ certain antipsychotics)
- Incapacity to give informed consent
- History of an eating disorder/ purging behaviour
- Previous gastric bypass/ banding
- Use of Leptin Therapy
- Untreated retinopathy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Total Dietary Replacement
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03900286